These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 35964134)
1. Revealing the crosstalk between nasopharyngeal carcinoma and immune cells in the tumor microenvironment. Jiang J; Ying H J Exp Clin Cancer Res; 2022 Aug; 41(1):244. PubMed ID: 35964134 [TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr Virus Induces Adipocyte Dedifferentiation to Modulate the Tumor Microenvironment. Liu SC; Tsang NM; Lee PJ; Sui YH; Huang CH; Liu TT Cancer Res; 2021 Jun; 81(12):3283-3294. PubMed ID: 33824135 [TBL] [Abstract][Full Text] [Related]
3. The immune escape mechanism of nasopharyngeal carcinoma. Li X; Guo Y; Xiao M; Zhang W FASEB J; 2023 Jul; 37(7):e23055. PubMed ID: 37358482 [TBL] [Abstract][Full Text] [Related]
4. Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma. Li W; Duan X; Chen X; Zhan M; Peng H; Meng Y; Li X; Li XY; Pang G; Dou X Front Immunol; 2022; 13():1079515. PubMed ID: 36713430 [TBL] [Abstract][Full Text] [Related]
5. Immunotherapy for nasopharyngeal carcinoma: Current status and prospects (Review). Huang H; Yao Y; Deng X; Huang Z; Chen Y; Wang Z; Hong H; Huang H; Lin T Int J Oncol; 2023 Aug; 63(2):. PubMed ID: 37417358 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus DNA seropositivity links distinct tumoral heterogeneity and immune landscape in nasopharyngeal carcinoma. Li W; Lv S; Liu G; Lu N; Jiang Y; Liang H; Xia W; Xiang Y; Xie C; He J Front Immunol; 2023; 14():1124066. PubMed ID: 36860875 [TBL] [Abstract][Full Text] [Related]
7. Metabolic reprogramming in nasopharyngeal carcinoma: Mechanisms and therapeutic opportunities. Liu Q; Bode AM; Chen X; Luo X Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):189023. PubMed ID: 37979733 [TBL] [Abstract][Full Text] [Related]
8. The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma. Tsang CM; Tsao SW Virol Sin; 2015 Apr; 30(2):107-21. PubMed ID: 25910483 [TBL] [Abstract][Full Text] [Related]
9. Targeting the crosstalk of epigenetic modifications and immune evasion in nasopharyngeal cancer. Looi CK; Foong LC; Chung FF; Khoo AS; Loo EM; Leong CO; Mai CW Cell Biol Toxicol; 2023 Dec; 39(6):2501-2526. PubMed ID: 37755585 [TBL] [Abstract][Full Text] [Related]
10. Nasopharyngeal Carcinoma Progression: Accumulating Genomic Instability and Persistent Epstein-Barr Virus Infection. Liu X; Deng Y; Huang Y; Ye J; Xie S; He Q; Chen Y; Lin Y; Liang R; Wei J; Li Y; Zhang J Curr Oncol; 2022 Aug; 29(9):6035-6052. PubMed ID: 36135044 [TBL] [Abstract][Full Text] [Related]
11. Influence of Epstein-Barr virus and human papillomavirus infection on macrophage migration inhibitory factor and macrophage polarization in nasopharyngeal carcinoma. Feng G; Xu Y; Ma N; Midorikawa K; Oikawa S; Kobayashi H; Nakamura S; Ishinaga H; Zhang Z; Huang G; Takeuchi K; Murata M BMC Cancer; 2021 Aug; 21(1):929. PubMed ID: 34407796 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr Virus Epithelial Cancers-A Comprehensive Understanding to Drive Novel Therapies. Han S; Tay JK; Loh CJL; Chu AJM; Yeong JPS; Lim CM; Toh HC Front Immunol; 2021; 12():734293. PubMed ID: 34956172 [TBL] [Abstract][Full Text] [Related]
13. Modulation of the tumor microenvironment by Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma. Yoshizaki T; Kondo S; Endo K; Nakanishi Y; Aga M; Kobayashi E; Hirai N; Sugimoto H; Hatano M; Ueno T; Ishikawa K; Wakisaka N Cancer Sci; 2018 Feb; 109(2):272-278. PubMed ID: 29247573 [TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma: A Brief Review. Xue F; He X Methods Mol Biol; 2020; 2204():99-107. PubMed ID: 32710318 [TBL] [Abstract][Full Text] [Related]
15. Clinical utility of circulating Epstein-Barr virus DNA analysis for the management of nasopharyngeal carcinoma. Fung SY; Lam JW; Chan KC Chin Clin Oncol; 2016 Apr; 5(2):18. PubMed ID: 27121878 [TBL] [Abstract][Full Text] [Related]
16. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma. Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748 [TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus infection and nasopharyngeal carcinoma. Tsao SW; Tsang CM; Lo KW Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893937 [TBL] [Abstract][Full Text] [Related]
18. Epigenomic landscape study reveals molecular subtypes and EBV-associated regulatory epigenome reprogramming in nasopharyngeal carcinoma. Ka-Yue Chow L; Lai-Shun Chung D; Tao L; Chan KF; Tung SY; Cheong Ngan RK; Ng WT; Wing-Mui Lee A; Yau CC; Lai-Wan Kwong D; Ho-Fun Lee V; Lam KO; Liu J; Chen H; Dai W; Lung ML EBioMedicine; 2022 Dec; 86():104357. PubMed ID: 36371985 [TBL] [Abstract][Full Text] [Related]
19. Association of Plasma Epstein-Barr Virus LMP1 and EBER1 with Circulating Tumor Cells and the Metastasis of Nasopharyngeal Carcinoma. Sun L; Wang Y; Shi J; Zhu W; Wang X Pathol Oncol Res; 2020 Jul; 26(3):1893-1901. PubMed ID: 31832991 [TBL] [Abstract][Full Text] [Related]
20. Transcriptomics of Epstein-Barr virus aids to the classification of T-cell evasion in nasopharyngeal carcinoma. Mahajan S; Bongaerts M; Hardillo J; Tsang A; Lo KW; Kortleve D; Ma B; Debets R Curr Opin Immunol; 2023 Aug; 83():102335. PubMed ID: 37235920 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]